0001628908-23-000072.txt : 20230605
0001628908-23-000072.hdr.sgml : 20230605
20230605162351
ACCESSION NUMBER: 0001628908-23-000072
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230601
FILED AS OF DATE: 20230605
DATE AS OF CHANGE: 20230605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WILLIAMS FRANK J
CENTRAL INDEX KEY: 0001204938
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37415
FILM NUMBER: 23992847
MAIL ADDRESS:
STREET 1: 800 NORTH GLEBE ROAD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolent Health, Inc.
CENTRAL INDEX KEY: 0001628908
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741]
IRS NUMBER: 320454912
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
BUSINESS PHONE: 571-389-6000
MAIL ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
4
1
wf-form4_168599661662369.xml
FORM 4
X0407
4
2023-06-01
0
0001628908
Evolent Health, Inc.
EVH
0001204938
WILLIAMS FRANK J
C/O EVOLENT HEALTH, INC.
800 NORTH GLEBE ROAD, SUITE 500
ARLINGTON
VA
22203
1
0
0
0
1
Class A Common Stock
2023-06-01
4
M
0
19060
6.87
A
838872
D
Class A Common Stock
2023-06-01
4
M
0
90940
10.27
A
929812
D
Class A Common Stock
2023-06-01
4
S
0
9091
29.27
D
920721
D
Class A Common Stock
2023-06-01
4
S
0
9969
29.75
D
910752
D
Class A Common Stock
2023-06-01
4
S
0
41914
29.26
D
868838
D
Class A Common Stock
2023-06-01
4
S
0
49026
29.74
D
819812
D
Class A Common Stock
66064
I
See footnote
Class A Common Option (right to buy)
6.87
2023-06-01
4
M
0
19060
0
D
2025-02-01
Class A Common Stock
19060.0
0
D
Class A Common Option (right to buy)
10.27
2023-06-01
4
M
0
90940
0
D
2026-03-01
Class A Common Stock
90940.0
17250
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2022.
Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.63 to $29.62, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.63 to $29.83, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.60 to $29.59, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.86, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares held of record by the Frank Williams Irrevocable Trust. Mr. Williams serves as the Trustee of the Frank Williams Irrevocable Trust.
The Class A Common Stock Options exercised vested on February 1, 2019.
The Class A Common Stock Options exercised vested on March 1, 2017, March 1, 2018, March 1, 2019, and March 1, 2020.
/s/ Jonathan Weinberg, Attorney-in-fact
2023-06-05